• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Analysis of islet antoantigens by the screening of a mouse islet cDNA expression library.

Research Project

Project/Area Number 07671166
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionKurume University

Principal Investigator

YAMADA Kentaro  Kurume University School of Medicine, Associate Professor, 医学部, 助教授 (10191305)

Co-Investigator(Kenkyū-buntansha) HAYASHI Hideki  Kurume University School of Medicine, Assistant Professor, 医学部, 助手 (50238119)
Project Period (FY) 1995 – 1996
KeywordsType 1 diabetes / NOD mouse / islet autoantigen / chromogranin A
Research Abstract

Two clones were obtained by immunoscreening of an NOD mouse islet lambdagt11 expression library with prediabetic NOD mouse sera. The clones (C17 and C18) were recognized by NOD mouse sera but not by Balb/c mouse sera. Antibodies against C17 and C18 fusion proteins were detected in 80% and 10% of sera from 10 week-old female NOD mice, respectively. DNA sequences of C18 were identical to mouse chromogranin A cDNA (596-1892). Nucleotide sequences of C17 showed a poly (A) tail and open reading frame for 46 amino acids. C17 mRNA was detected by the Northern blot analysis in the pancreas and brain tissue. A nucleotide sequence with high homology with C17 was found in human pancreas cDNA.The sequence was cloned in a plasmid vector for further analysis. Antibodies to chromogranin A were measured by radioimmunoassays using as antigens in vitro transcribed and translated [^<35>S]-methionine-labeled mouse chromogranin A.The prevalence of anti-chromogranin A was approximately 10% in prediabetic female NOD mice. Whereas, the C17 antibody radioassay was not sensitive enough to measure titers of circulating antibodies. We also measured ICA512 (IA-2) antibodies in human subjects with the in vitro transcribed and translated [^<35>S]-methionine-labeled ICA512. The frequency of the ICA512 antibodies was higher in acute-onset IDDM than slowly progressive IDDM.The frequency and titer of ICA512AA declined sharply within 5 years after the onset of IDDM,suggesting the association of the antibody and acute beta-cell destruction.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Kentaro Yamada,et al.: "Combined Measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM" Diabetes Research and Clinical Practice. (印刷中). (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kentaro Yamada,et al.: "Mouse islet lysis mediated by interleukin-1-induced Fas" Diabetologia. 39. 1306-1312 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kentaro Yamada,et al.: "Endogenous tumor necrosis factor-α production by a pancreatic β-cell line : inhibitory effects of hydrocortisone and nicotinamide" Life Sciences. 59. 1423-1429 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kentaro Yamada, Xiahong Yuan, Chizuko Inada, Hideki Hayashi, Ken-ichi Koyama, Fumi Ichikawa, George S.Eisenbarth, Kyohei Nonaka: "Combined Measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM." Diabetes Research and Clinical Practice. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Yamada, N.Takane-Gyotoku, X.Yuan, F.Ichikawa, C.Inada, K.Nonaka.: "Mouse islet cell lysis mediated by interleukin-1-induced Fas." Diabetologia. 39-11. 1306-1312 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kentaro Yamada, Naoko Takene-Gyotoku, Chizuko Inada, Kyohei Nonaka.: "Endogenous tumor necrosis factor-alpha production by a pancreatic beta-cell line : inhibitory effects of hydrocortisone and nicotinamide." Life Sciences. 59-17. 1423-1429 (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi